GMED analyst estimates
Globus Medical (GMED) analyst ratings, the average price target and its range, and every firm's latest call.
GMED analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 1, 2026 | RBC Capital | Globus Medical price target lowered to $85 from $115 at RBC Capital | $85.00 |
| Jul 28, 2026 | UBS | Globus Medical initiated with a Neutral at UBS | $82.00 |
| Jul 16, 2026 | Truist Financial | Globus Medical price target lowered to $100 from $115 at Truist | $100.00 |
| Jul 13, 2026 | RBC Capital | Globus Medical price target lowered to $115 from $120 at RBC Capital | $115.00 |
| Jul 8, 2026 | Stifel Nicolaus | Globus Medical (GMED) PT Lowered to $80 at Stifel on 'Modest Upside Potential'Member Login | $80.00 |
| Jul 8, 2026 | BMO Capital | Globus Medical initiated with an Outperform at BMO Capital | $94.00 |
| Jun 15, 2026 | Piper Sandler | Globus Medical price target lowered to $100 from $115 at Piper Sandler | $100.00 |
| May 8, 2026 | Wells Fargo | Globus Medical price target lowered to $103 from $104 at Wells Fargo | $103.00 |
| May 8, 2026 | Needham | Globus Medical price target raised to $117 from $114 at Needham | $117.00 |
| Feb 25, 2026 | Truist Financial | Globus Medical price target raised to $115 from $105 at Truist | $115.00 |
| Jan 30, 2026 | Needham | Globus Medical upgraded to Buy from Hold at Needham | $112.00 |
| Jan 26, 2026 | Cowen & Co. | Globus Medical initiated with a Buy at TD Cowen | $110.00 |
| Jan 9, 2026 | Canaccord Genuity | Globus Medical price target raised to $112 from $105 at Canaccord | $112.00 |
| Jan 8, 2026 | Piper Sandler | Globus Medical price target raised to $115 from $90 at Piper Sandler | $115.00 |
| Dec 17, 2025 | RBC Capital | Globus Medical price target raised to $100 from $92 at RBC Capital | $100.00 |
- 13 firms rate GMED: 10 buy, 3 hold, 0 sell.
- The average price target is $95.12 from 8 analysts, from $80.00 to $117.00.
Updated 2026-11-03 00:02 UTC